http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102924594-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b51619c4c541c872f86910f69003b4bb |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 |
| filingDate | 2012-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_801683d7615c6a0525bfb4a0c0c9ba2f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5d839bd35a0ab65c55b9e84bf90bffe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39f7eb86072cb306b61277c8aaa95ce4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_024bc0ca83fa4efd46f58467e832519f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b90192e3e070b88b8a583af9cfb96c0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_509b2b7f132ea2736f67b43b3f8ce923 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f38085db7e64002c8858428f10ad917f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2a52d76ceadd278a484f6a3ea2b0805 |
| publicationDate | 2014-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102924594-B |
| titleOfInvention | Anti-tumor-protein-P63 monoclonal antibody and purpose thereof |
| abstract | The invention discloses a hybridoma cell line (with a collection number of CGMCC No.6131) and a monoclonal antibody 2B10 produced by the monoclonal antibody. The invention also related to an application of the monoclonal antibody 2B10 in preparing an immunoassay tool used for detecting a P63 protein, an immunohistochemical kit containing the monoclonal antibody 2B10, and the applications of the monoclonal antibody 2B10 in preparing kits used for identifying P63-positive cells or P63-positive-cell source tumors. The monoclonal antibody provided by the invention can be specifically combined with P63 protein, and has no cross-reaction with other proteins in the cell. Therefore, P63 protein immunoassay specificity and reliability are substantially improved. |
| priorityDate | 2012-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 64.